Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning.
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Genes involved in complex adaptive processes tend to have highly conserved upstream regions in mammalian genomes.
